Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9H2M9: Variant p.Arg426Cys

Rab3 GTPase-activating protein non-catalytic subunit
Gene: RAB3GAP2
Feedback?
Variant information Variant position: help 426 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Arginine (R) to Cysteine (C) at position 426 (R426C, p.Arg426Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In MARTS1; abolishes GEF activity towards RAB18. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 426 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 1393 The length of the canonical sequence.
Location on the sequence: help GRVILLDVARGIAIRMWKGY R DAQIGWIQTVEDLHERVPEK The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         GRVILLDVARGIAIRMWKGYRDAQIGWIQTVEDLHERVPEK

Mouse                         GRVILLDVARGIAIRMWKGYRDAQVGWIQIVEDLHERVPEK

Rat                           GRVILLDVARGIAIRMWKGYRDAQIGWIQIVEDLHERVPEK

Caenorhabditis elegans        ARVLVIDIASRQVVLIFKGYRDASISWVSVTED--------

Drosophila                    DRVMLVDTHQAIILRVWKGYRDAQCAFVPVKEK--------
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 1393 Rab3 GTPase-activating protein non-catalytic subunit
Alternative sequence 207 – 1393 Missing. In isoform 2.



Literature citations
Mutation spectrum in RAB3GAP1, RAB3GAP2, and RAB18 and genotype-phenotype correlations in Warburg micro syndrome and Martsolf syndrome.
Handley M.T.; Morris-Rosendahl D.J.; Brown S.; Macdonald F.; Hardy C.; Bem D.; Carpanini S.M.; Borck G.; Martorell L.; Izzi C.; Faravelli F.; Accorsi P.; Pinelli L.; Basel-Vanagaite L.; Peretz G.; Abdel-Salam G.M.; Zaki M.S.; Jansen A.; Mowat D.; Glass I.; Stewart H.; Mancini G.; Lederer D.; Roscioli T.; Giuliano F.; Plomp A.S.; Rolfs A.; Graham J.M.; Seemanova E.; Poo P.; Garcia-Cazorla A.; Edery P.; Jackson I.J.; Maher E.R.; Aligianis I.A.;
Hum. Mutat. 34:686-696(2013)
Cited for: VARIANT MARTS1 CYS-426; Rab18 and a Rab18 GEF complex are required for normal ER structure.
Gerondopoulos A.; Bastos R.N.; Yoshimura S.; Anderson R.; Carpanini S.; Aligianis I.; Handley M.T.; Barr F.A.;
J. Cell Biol. 205:707-720(2014)
Cited for: CHARACTERIZATION OF VARIANT MARTS1 CYS-426; FUNCTION; SUBCELLULAR LOCATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.